Heart Failure Clinical Trial

Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in HF Patients (CONFIRM-HF)

Summary

A research study to determine if heart failure can be medically managed using data collected from cardiac monitoring devices

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

At least 18 years of age
Admission for worsening of HF
Discharged to home
Have appropriate cardiac device with OptiVol® implanted for at least 34 days prior to enrollment
Enrolled in Carelink® system and able to transmit data
Able to participate for at least 3 months

Exclusion Criteria:

Post heart transplant or actively listed
End-stage (Stage D) HF, including treatment with chronic ionotropic drugs or left ventricular assist device support
Stage IV or V chronic renal dysfunction (GFR <25 mol/min per 1.73 M2)
Severe Chronic Obstructive Pulmonary Disease (COPD) requiring home oxygen
Severe pulmonary hypertension not due to left-sided HF

Study is for people with:

Heart Failure

Study ID:

NCT02026635

Recruitment Status:

Withdrawn

Sponsor:

Thomas Jefferson University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Study ID:

NCT02026635

Recruitment Status:

Withdrawn

Sponsor:


Thomas Jefferson University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider